Collectively, these findings reveal that TP-0903 treatment induced apoptosis, MMP loss, and activation of apoptotic signaling, and downregulated anti-apoptotic Mcl-1 and Bcl-2 in NB cells. This evidence concerns the gene BCL2 and neuroblastoma.